Allergan bonds gap out on news of Valeant bid

By Danielle Robinson Allergan, the pharma giant behind Botox, saw its bonds plunge some 10 points Tuesday on news that activist investor William Ackman is leading an attempted hostile takeover of the company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.